Open AccessNew validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials
Author(s) -
Thierry Gorlia,
Wenting Wu,
M. Wang,
Brigitta G. Baumert,
Minesh P. Mehta,
Jan C. Buckner,
Edward Shaw,
Paul D. Brown,
Roger Stupp,
Evanthia Galanis,
Denis Lacombe,
Martin J. van den Bent
Publication year - 2013
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/not117
Subject(s) - medicine , clinical trial , oncology , population , homogeneous , progression free survival , cancer , overall survival , pathology , physics , thermodynamics , environmental health
In a previous study, the European Organisation for Research and Treatment of Cancer (EORTC) reported a scoring system to predict survival of patients with low-grade gliomas (LGGs). A major issue in the diagnosis of brain tumors is the lack of agreement among pathologists. New models in patients with LGGs diagnosed by central pathology review are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom